- Home
- QSI vs INMB Comparison
QSI vs INMB Comparison
Compare QSI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- INMB
- Stock Information
- Founded
- QSI 2013
- INMB 2015
- Country
- QSI United States
- INMB United States
- Employees
- QSI N/A
- INMB N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- INMB Health Care
- Exchange
- QSI Nasdaq
- INMB Nasdaq
- Market Cap
- QSI 214.3M
- INMB 176.5M
- IPO Year
- QSI N/A
- INMB 2019
- Fundamental
- Price
- QSI $1.26
- INMB $6.97
- Analyst Decision
- QSI Strong Buy
- INMB Strong Buy
- Analyst Count
- QSI 3
- INMB 3
- Target Price
- QSI $3.42
- INMB $24.33
- AVG Volume (30 Days)
- QSI 2.7M
- INMB 215.6K
- Earning Date
- QSI 05-15-2025
- INMB 05-08-2025
- Dividend Yield
- QSI N/A
- INMB N/A
- EPS Growth
- QSI N/A
- INMB N/A
- EPS
- QSI N/A
- INMB N/A
- Revenue
- QSI $3,058,000.00
- INMB $50,000.00
- Revenue This Year
- QSI $151.18
- INMB N/A
- Revenue Next Year
- QSI $172.07
- INMB N/A
- P/E Ratio
- QSI N/A
- INMB N/A
- Revenue Growth
- QSI 182.63
- INMB N/A
- 52 Week Low
- QSI $0.61
- INMB $4.32
- 52 Week High
- QSI $5.77
- INMB $11.76
- Technical
- Relative Strength Index (RSI)
- QSI 51.74
- INMB 40.42
- Support Level
- QSI $1.15
- INMB $6.98
- Resistance Level
- QSI $1.35
- INMB $8.00
- Average True Range (ATR)
- QSI 0.07
- INMB 0.49
- MACD
- QSI 0.02
- INMB -0.07
- Stochastic Oscillator
- QSI 64.71
- INMB 6.59
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.